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The role of aluminum in the development of hypercalcemia in the rat.
The present study evaluates the effect of an intravenous (i.v.) aluminum
infusion on total and ionized calcium. Seven groups of rats were
studied, and it was found that the magnitude of hypercalcemia was dose
dependent. During a two hour i.v. infusion containing 0.4 mg aluminum
per 100 grams of body weight, the total plasma calcium increased from
9.7 0.2 to 12.7 0.7 mgldl (X SE, P < 0.02) while the ionized
calcium decreased from 5.1 0.12 to 4.05 0.24 mg/dl (P < 0.001). The
increase in plasma calcium occurred in intact and parathyroidectomized
rats, and the hypercalcemia could not be attributed to changes in PTH,
arterial pH, plasma protein, or plasma phosphate. In vitro studies
indicate that the addition of aluminum to rat plasma results in decreased
ionized calcium concentration. Similarly, ultrafilterable calcium de-
clined from 5.4 0.17 to 4.53 0.12 mg/dl (P <0.001) after the addition
of aluminum to rat plasma. In summary, high levels of intravenous
aluminum increase total plasma calcium and decrease ionized calcium.
As also supported by in vitro data, the most probable mechanism is
increased binding of calcium in the plasma which decreases ionized
calcium. As a result of the decreased concentration of ionized calcium,
movement of bone and interstitial calcium into the vascular space may
occur, thus increasing total plasma calcium.
During a study to evaluate the effect of an intravenous
aluminum infusion on parathyroid hormone (PTH) secretion
[1], it became apparent that intravenous aluminum produced
hypercalcemia. This observation has been made previously in
the dog during repeat injections of intravenous aluminum,
where the hypercalcemia became sustained and progressive [2].
At that time, the possibility that aluminum may directly elevate
serum calcium levels was considered. In a recent study, the
addition of aluminum to the incubation medium of parathyroid
tissue produced a decrease in ionized calcium [3]. The purpose
of the present study is to evaluate the effect of an intravenous
aluminum infusion on the plasma levels of total and ionized
calcium.
Methods
Male Wistar rats weighing 450 to 650 g were divided into
seven groups. In Groups I and II, both receiving a calcium—free
peritoneal dialysis, the effect of intravenous aluminum admin-
istration on plasma calcium concentration (Group II) was
compared to a control (Group I). In Groups III through VII,
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studies were performed to delineate the mechanism by which
intravenous aluminum administration may affect the plasma
calcium level.
The seven groups included in this study are: Group I,
controls, received a two hour peritoneal dialysis with a calcium
free dialysate (sodium 132 mEq/liter, chloride 105 mEq/liter,
magnesium 1.5 mEq/liter, glucose 250 mg/dl, potassium 4
mEq/liter, and bicarbonate 30 mEq/liter). Group II, received
peritoneal dialysis as in Group I, simultaneously with an i.v.
infusion containing 0.4 mg of aluminum per 100 g of body
weight. Since hypercalcemia was observed in Group II, two
additional groups (III and IV), in which both total and ionized
calcium measurements were obtained, were studied without
peritoneal dialysis to delineate the cause of hypercalcemia.
Group III received a two—hour intravenous infusion containing
0.4 mg of aluminum per 100 g of body weight; and Group IV
received a two—hour i.v. infusion containing 0.2 mg of alumi-
num per 100 g of body weight. In order to learn if an i.v.
aluminum infusion affected the measurement of calcium in the
absence of P1'H, parathyroidectomy was performed in Group
V, which subsequently received a two—hour i.v. infusion con-
taining 0.4 mg of aluminum per 100 g of body weight. Group VI
was identical to Group III, except that plasma phosphate, total
protein, arterial pH, and blood gases were measured during the
aluminum administration. Group VII represented a control
group for Group VI, and plasma phosphate, total protein,
arterial pH, and blood gases were measured during diluent
administration. In all groups receiving i.v. aluminum, aluminum
chloride was dissolved in 5% dextrose and water, and admin-
istered at a rate of 0.014 ml per minute. A schematic diagram of
the seven groups is shown in Figure 1.
In Groups I and lithe volume of peritoneal dialysis instilled
was 17% of total body weight. The instillation was done through
an 18 gauge angiocath that remained in place during the study.
In Group II, the aluminum infusion was begun 20 minutes prior
to the initiation of a two-hour peritoneal dialysis and continued
throughout the dialysis. Thus, in this group the first measure-
ment of calcium was obtained 20 minutes after the initiation of
the aluminum infusion. Subsequent samples were obtained after
30 and 120 minutes of peritoneal dialysis. In Group II, ionized
calcium was measured after 120 minutes of peritoneal dialysis in
9 rats. In Groups I and II, plasma and dialysate calcium were
obtained prior to peritoneal dialysis (0') and after 30 and 120
minutes. In Group VI, the first measurement of total plasma
calcium, phosphate, and total protein was obtained prior to the
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Fig. 1. All seven groups are graphically represented. Symbols are: ()
calcium—free peritoneal dialysis; () Al iv. 0.2 mgIlOO g body wt; (•)
Al iv. 0.4 mg/l00 g body wt; () dextrose 5%.
initiation of the aluminum infusion (0'), and subsequent samples
at 30 and 120 minutes. Arterial pH and blood gases were
measured at 120 minutes. Group VII was handled the same as
Group VI except that the measurements were obtained during
diluent administration.
To provide a reference value for the plasma aluminum
concentration, three rats not included in any group were infused
with 0.4 mg of aluminum per 100 g of body weight beginning 20
minutes prior to peritoneal dialysis with a calcium free dialy-
sate, and plasma aluminum was measured at 0, 30, and 120
minutes after the start of peritoneal dialysis.
To eliminate the possibility of interference of the calcium
determination by aluminum, aluminum was added to a calcium
standard, (10 mgldl), to achieve aluminum concentrations of
10,000, 20,000, and 40,000 tg/liter. Aluminum was also added
to plasma obtained from normal rats to achieve the above
concentrations. In both instances, no interference with total
calcium determinations was observed. In addition, aluminum
was added to normal rat plasma in vitro to achieve concentra-
tions of 5000, 10,000, and 20,000 pg/liter. The blood pH
remained within the 7.3 to 7.4 range. The addition of aluminum
in the above concentrations resulted in a progressive decrease
in ionized calcium, and these data are shown in the Results. The
addition of aluminum to ionized calcium standard to achieve
aluminum concentrations of 1000, 5000, 20,000, and 40,000
g!liter did not decrease ionized calcium levels,
The effect of aluminum on ultrafilterable calcium in vitro was
studied by the ultrafiltration of plasma samples from the same
rat, before and after the addition of aluminum to the sample.
Aluminum was added in vitro to achieve a concentration of
20,000 tg/liter. The ultrafiltration was performed in a chamber
specifically designed for ultrafiltration (Amicon, Model 8 MC,
Lexington, Massachusetts, USA). The membrane (Amicon,
Model UM-lO) used for the study is permeable to molecules less
than 10,000 molecular weight.
Rats were anesthetized with Nembutal (100 mg/kg). Prior to
peritoneal dialysis, a PE-50 catheter for blood sampling was
placed in the jugular vein and extended into the superior vena
cava. Blood (2.5 ml) was obtained immediately prior to instil-
lation of peritoneal dialysate. Blood was centrifuged in a
refrigerated centrifuge, and the plasma and packed red blood
cells separated. After removal of the plasma, 0.9% saline was
added to the packed red blood cells to produce a total volume of
2.5 ml, and this was infused via the jugular catheter. The
hematocrits measured before and after the experiment were not
significantly different. Dialysate (4 ml) was obtained immedi-
ately after instillation into the peritoneal cavity, and at 30 and
120 minutes after the instillation of peritoneal dialysate.
Total plasma calcium levels were determined with an auto-
mated calcium analyzer (Calcette, model 4008, Precision Sys-
tems, Inc., Sudbury, Massachusetts, USA). Ionized calcium
was measured with an ionized calcium analyzer (Space-Stat 20,
Orion Biomedical, Cambridge, Massachusetts, USA). The sam-
ples for ionized calcium were frozen and when measured were
corrected for pH. Measurement of ionized calcium was per-
formed within 24 hours after freezing; this has been reported
not to alter the ionized calcium concentration [4]. Plasma
aluminum was determined by a method adapted from LeGendre
and Alfrey [51. Samples were analyzed in a Perkin Elmer
graphite furnace utilizing a Perkin Elmer HGA 2100 controller,
AS-I autosampling device, deuterium background corrector,
ramp accessory, and a Perkin Elmer 2380 atomic absorption
spectrophotometer. Plasma phosphate was measured with a
specific kit for phosphate (Fast Phosphorus Test Set, Stanbio,
San Antonio, Texas, USA). Arterial pH and blood gases were
determined with an arterial blood gas analyzer (Instrumentation
Laboratory, pH/Blood gas analyzer, Cidra, Puerto Rico). Total
protein was measured by spectrophotometry [6].
Statistical analysis was performed using the paired and
unpaired t-test. Results are expressed as the mean value SE.
Results
Changes in plasma calcium concentration during peritoneal
dialysis are shown in Table I and Figure 2. In Group I, the
plasma calcium decreased from baseline after 30 (P < 0.005)
and 120 (P < 0.005) minutes of a calcium—free peritoneal
dialysis. In Group II, the plasma calcium concentration was
elevated during the aluminum infusion despite a calcium—free
peritoneal dialysis. The elevated plasma calcium concentration
in Group II at the initiation of peritoneal dialysis is explained by
the fact that the aluminum infusion was begun 20 minutes
before baseline plasma—calcium levels were obtained. Despite
an elevated, total plasma calcium—level at 120 minutes, the
ionized calcium concentration was decreased.
The magnitude of calcium removal with peritoneal dialysis
was similar and progressive in both Groups I and II. As shown
in Figure 3, the amount of calcium removed at the end of 120
minutes of peritoneal dialysis is comparable in the two groups.
In Group III, the total plasma calcium increased from 9.7
0.2 to 12.7 0.7 mgldl (P < 0.02) and the ionized calcium
768 Rodriguez et a!
Table 1. Biochemical data
Group I
Total calcium, mg/dl
N 8
Minutes
0 9.0±0.3
30 7.8 0.3"
120 7.9 0.3"
Ionized calcium, mg/dl
N
Minutes
Mean SE
"p <0.05 Compared to baseline
9 8
5.10 0.12
4.40 0.22"
3.00 0.20 4.05 0.24a
6
4.90 0.08
4.56 0.10"
4.58 0.10"
Time, mm
Fig. 2. The change in total calcium during a 2 hour study period is
shown in Groups: (•) 1; (0) 11; (U) II!; and (LI) IV. The total plasma
calcium concentration for Group II at —20 minutes was not measured
but represents the mean baseline concentration for Groups 1, 111, and
IV, all of which were obtained prior to aluminum exposure. * p < 0.05
compared to 0 minute value.
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120 Fig. 3. Calcium removal via peritoneal dialysis is shown in Group I (•)
and Group II (0). The values are similar for both groups.
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decreased from 5.1 0.12 to 4.05 0.24 mg/dl (P < 0.001)
during the two hour infusion (Table 1, Figs. 2 and 4). In Group
IV, the total plasma calcium increased from 9.7 0.14 to 10.05
0.14 mgldl (P < 0.02) and the ionized calcium decreased from
4.9 0.08 mg/dl to 4.58 0.10 mg/dI (P < 0.02) during the
two—hour aluminum infusion. In Group II, the total calcium was
less but not significantly different at the end of two hours. In
both Groups H and III, the ionized calcium was less than Group
IV (P < 0.001) at two hours.
Figure 5 displays the plasma ionized calcium as a percent of
total calcium. In Groups III and IV, the baseline ionized
calcium was slightly greater than 50% of the total calcium. The
percentage fell progressively and by 120 minutes, the percent
ionized calcium was less in Group III than Group IV (P <
0.001). Similarly in Group II, the percent ionized calcium was
less than Group IV (P <0.001).
Three additional rats were infused with i.v. aluminum at a
dose of 0.4mg per 100 g of body weight in the same protocol as
Group II; as shown in Figure 6, the plasma aluminum concen-
tration increased rapidly and remained between 18,000 and
34,000 pg/liter during the study.
In Group V the plasma calcium decreased from 10.3 0.2 to
7.9 0.1 mg/dI three days after parathyroidectomy. After 120
minutes of i.v. aluminum administered at a dose of 0.4 mg per
100 g of body weight, the plasma calcium increased to 9.7 0.7
mgldl (P < 0.05).
Total plasma protein, plasma phosphate, and arterial pH
were studied in Groups VI and VII, and these data are dis-
played in Table 2. In Group VI, total protein did not change
from baseline and was not different from Group VII; arterial pH
at 120 minutes showed a mild respiratory alkalosis and no
significant differences existed between the two groups. In
Group VI, arterial pCO2 was 32.1 1.3 versus 34.3 2.6 mm
Hg (NS) in Group VII. Plasma phosphate in Groups VI and VII
was not significantly different at baseline (0'). However, plasma
phosphate increased in Group VI when compared to Group VII
at 30 (P < 0.001) and 120 (P < 0.001) minutes. In Group VI,
total calcium increased from 10.3 .2 to 14.6 .6 at 120
minutes. While no difference existed at baseline, total calcium
was greater at 30 (P < 0.001) and 120 (P < 0.001) minutes in
Group VI when compared to Group VII.
Aluminum was added in vitro to rat plasma. The measure-
ment of total calcium before and after the addition of aluminum
was not different. However, as shown in Figure 7, ionized
calcium fell progressively from 5.1 0.09 to 4.24 0.12 mgldl
as the concentration of aluminum increased. Similarly,
ultrafilterable calcium declined from 5.4 0.17 to 4.53 0.12
mg/dl (P < 0.001) after the addition of aluminum, to achieve a
concentration of 20,000 sglliter.
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Fig. 5. The percent ionized calcium of total plasma calcium is shown
during the i.v. aluminum infusion. There was a progressive decline in
120 percent ionized calcium in Group III (0), and Group IV (U). In Group
Time, mm 11(0), the percent ionized calcium is shown at 120 minutes. * P < 0.05
compared to the 0 minute value.
Fig. 4. Ionized plasma calcium concentrations during intravenous
aluminum infusion are shown in Group II (0), Group III (0), and
Group IV (U). * P < 0.05 compared to 0 minute value.
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Fig. 6. Plasma aluminum concentrations are shown in three rats in
which an intravenous aluminum infusion containing 0.4 mg/100 g of
body wt was begun 20 minutes before the start of a calcium—free
peritoneal dialysis and continued throughout the two—hour peritoneal
dialysis.
Discussion
Despite a two hour, calcium—free peritoneal dialysis and
significant calcium removal, an intravenous infusion of alumi-
num resulted in hypercalcemia. As shown in Figure 3, a
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aluminum induced changes in plasma calcium excludes PTH as
an important pathogenic factor. The reason that the baseline
mean plasma calcium level was not lower than 7.9 0.1 mgldl
is probably related to two factors. First, only three days had
expired following the parathyroidectomy and second, the rats
were maintained on a normal calcium diet containing 1.2%
calcium [8].
Plasma proteins may alter the calcium bound fraction [9].
However, the absence of a change in total protein indicates that
an increase in protein did not contribute to the observed
increase in the non-filterable portion of calcium. Another factor
which may affect plasma calcium is blood pH. Since a mild
respiratory alkalosis of a similar magnitude was found in both
groups, it is unlikely that blood pH is a contributing factor. A
decline in plasma phosphate plasma has been observed to
increase plasma calcium [10]. In this study, the i.v. infusion of
aluminum produced an increase in plasma phosphate. This
increase should, if anything, result in a decline in plasma
calcium and not an increase. Thus, the increment in plasma
phosphate does not explain the observed increase in plasma
calcium. An explanation for the increment in plasma phosphate
is not available.
Although the addition of aluminum to plasma in vitro in-
creased the bound calcium and decreased ionized calcium, total
calcium did not change, presumably because recruitment of
calcium from other sites cannot occur in a test tube. However,
increases in plasma aluminum resulted in a progressive decline
in ionized calcium. Also, the addition of aluminum to ionized
calcium standard did not decrease ionized calcium levels. Thus,
it is unlikely that the in vivo addition of aluminum to blood
results in an artifactual decrease in ionized calcium. Similar
findings were recently reported by Bourdeau et al [3]. In that
study, the addition of aluminum to parathyroid tissue incuba-
tion medium resulted in a decrease in the fraction of ionized to
total calcium.
20000 The presence of high concentrations of aluminum in the blood
clearly affects the plasma calcium concentration. From this
study, it appears that aluminum increased the fraction of
bound—nonfiltrable calcium in the plasma, which, in turn,
lowered ionized calcium. Since, as shown in vitro, the addition
of aluminum does not interfere with the measurement of cal-
cium levels for change to occur in vivo, recruitment of calcium
must occur. Thus, findings suggest a new equilibrium is formed
in the plasma between bound calcium and ionized calcium, and
calcium in bone and the interstitial space. A conceptual model
of this hypothesis is shown in Figure 8. It is clear that the
present study only suggests the existence of an aluminum
induced increase in calcium binding, the mechanism of which
needs to be evaluated.
While hypercalcemia has been reported in dialysis patients
with aluminum—associated osteomalacia, there is no evidence
to indicate that plasma aluminum directly produces hypercal-
cemia in these patients. In the present study, levels of plasma
aluminum are approximately 40- to 100-fold higher than those
reported in dialysis patients with aluminum—associated osteo-
malacia. As shown in Figure 7, extrapolation of the in vitro data
indicate that plasma levels of aluminum observed in the dialysis
patients with aluminum—associated osteomalacia would pro-
duce insignificant changes in ionized plasma calcium concen-
tration.
Table 2. Total plasma protein, plasma phosphate, and arterial pH in
aluminum and non-aluminum infused rats
Minutes VI VII
Total protein, gid!
0 5.79 0.16 5.61 0.18
30 5.62 0.15 5.57 0.26
120 5.10 0.10 5.27 0.20
Plasma phosphate, mgldl
0 8.15 0.23 7.31 0.31
30 9.75 0.32' 7.40 0.33
120 12.36 o.sla 7.36 0.30
Arterial pH
120 7.50 0.02 7.50 0.02
Mean SE.
a p < 0.001 Group VI vs. Group VII at same time interval
6.0
5000 10000
Aluminum concentration, jig/mi
5.6
E
5.2
. 4.80.
a)N
C0
4.4
4.0
Fig. 7. The addition of aluminum to rat plasma in vitro decreased the
concentration of ionized calcium. The plasma ionized calcium concen-
tration decreases as the plasma aluminum concentration increases.
comparable amount of calcium was removed in Groups I and II.
This finding is important because with hypercalcemia, a pro-
portional increase in ultrafilterable calcium is expected and
should result in greater calcium removal in Group II. This did
not occur, presumably because the ionized calcium concentra-
tion did not increase in Group II despite the presence of
aluminum—induced hypercalcemia. In Groups III and IV, the
hypercalcemia appears to be dose—dependent, being greater
with the higher dose of i.v. aluminum. In addition, despite
hypercalcemia, ionized calcium levels were decreased (Fig. 4)
with both doses of aluminum at the conclusion of the 120-
minute aluminum infusion.
The finding of hypercalcemia as a result of i.v. aluminum
administration does not appear to be unique to aluminum. It has
also been reported with the i.v. administration of lead [7].
Factors which potentially affect plasma calcium were evalu-
ated. The finding that parathyroidectomy does not affect the
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Fig. 8. A conceptual mode! of the effect of aluminum on calcium
homeostasis in blood. Before the addition of aluminum, bound calcium
(RCa) is in equilibrium with ionized calcium in the blood. The ionized
calcium in the blood is in equilibrium with ionized calcium in the
interstitium including bone. After the addition of aluminum to the
blood, calcium homeostasis in altered. The aluminum increases the
bound calcium either by increasing binding by the bound fraction
(AL-RCa) or directly complexing calcium (AL-Ca); thus, ionized cal-
cium is decreased. As a result of decreased ionized calcium in the
plasma, ionized calcium is mobilized from the interstitium to restore
normal levels. As a consequence of movement of interstitial calcium to
the blood, more ionized calcium is available for binding. This results in
increased total calcium, increased bound calcium, and decreased ion-
ized calcium.
elevation of plasma aluminum increases total plasma calcium
and decreases ionized plasma calcium. A hypothetical mecha-
nism may be increased binding of calcium in the plasma which
thus decreases ionized plasma calcium. As a result of the
decreased fraction of ionized calcium, movement of bone and
interstitial calcium into the vascular space may occur, thus
increasing total plasma calcium.
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A study in the dog has shown that the administration of i.v.
aluminum resulted in elevation of total plasma calcium [2].
When ionized calcium was measured after 10 and 20 days of i.v.
aluminum administration, it was found to be normal despite the
presence of hypercalcemia. Our data would suggest that the
hypercalcemia observed in that study is secondary to increased
calcium binding in the plasma, and that ionized calcium may
have been normal because sufficient time had elapsed after the
infusion of i.v. aluminum for a state of equilibrium to be
established between plasma ionized calcium, bound calcium in
the plasma, and bone and interstitial calcium. Since large doses
of aluminum are given to animals both to produce osteomalacia
and to assess parathyroid gland function [2, 11, 12], measure-
ment of total calcium concentration must be interpreted care-
fully.
In summary, our results indicate that an acute marked
